Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Opioid
18 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Opioid
Trevena Announces FDA Approval of OLINVYK Injection
PR-M08-20-NI-30
Opioid Disorder
Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder
PR-M06-20-NI-014
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
PAO-M07-19-NI-021
Opioid Abuse
Opioid Abuse is Linked to a Rise in Infectious Diseases
PAO-M07-19-NI-016
Opioid Crisis
Analysis of Medicare Prescriptions Uncovers Role Surgeons Played in Opioid Crisis
PAO-M07-19-NI-002
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
PAO-M06-19-NI-006
Pain Treatment
Eli Lilly Acquires Rights to Non-Opioid Pain Treatment
PAO-M05-19-NI-038
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
PAO-M05-19-NI-006
Opioids
FDA Grants Competitive Generic Therapy (CGT) Designation to Purdue Pharma’s Investigational Nalmefene HCl Injection
PR-M04-19-NI-080
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
PAO-M04-19-NI-012
Investment
New Opioid-alternative Raises $3.25 Million for Phase I Trials
PR-M01-19-NI-037
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Opioids
Proposed Opioid Bill Includes New Payment Disclosures
PAO-M10-18-NI-007
FDA Approval
Camargo Congratulates US WorldMeds on Obtaining FDA Approval for the First Non-Opioid Medicine for the Management of Opioid Withdrawal Symptoms
PR-M07-18-NI-027
FDA Approval
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
PR-M06-18-NI-063
Clinical Data
New Data for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy
PR-M06-18-NI-058
FDA Approval
New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA
PAO-M05-18-NI-019
FDA Approval
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
PR-M05-18-NI-079
.svg)
